• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global low-concentration atropine market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global low-concentration atropine market 2018 – 2022 ($ million)
o 4.2 Type Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Type Segment 2018 – 2022 ($ million)
o 4.3 Application Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Application Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type – Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Atropine sulfate 0.01 percentage – Market size and forecast 2023-2028
o Exhibit 34: Chart on Atropine sulfate 0.01 percentage – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Atropine sulfate 0.01 percentage – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Atropine sulfate 0.01 percentage – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Atropine sulfate 0.01 percentage – Year-over-year growth 2023-2028 (%)
o 6.4 Atropine sulfate 0.025 percentage – Market size and forecast 2023-2028
o Exhibit 38: Chart on Atropine sulfate 0.025 percentage – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Atropine sulfate 0.025 percentage – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Atropine sulfate 0.025 percentage – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Atropine sulfate 0.025 percentage – Year-over-year growth 2023-2028 (%)
o 6.5 Atropine sulfate 0.05 percentage – Market size and forecast 2023-2028
o Exhibit 42: Chart on Atropine sulfate 0.05 percentage – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Atropine sulfate 0.05 percentage – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Atropine sulfate 0.05 percentage – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Atropine sulfate 0.05 percentage – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ million)
o Exhibit 47: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 48: Chart on Application – Market share 2023-2028 (%)
o Exhibit 49: Data Table on Application – Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 50: Chart on Comparison by Application
o Exhibit 51: Data Table on Comparison by Application
o 7.3 Child – Market size and forecast 2023-2028
o Exhibit 52: Chart on Child – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Child – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Child – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Child – Year-over-year growth 2023-2028 (%)
o 7.4 Adult – Market size and forecast 2023-2028
o Exhibit 56: Chart on Adult – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Adult – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Adult – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Adult – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ million)
o Exhibit 61: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2023-2028 (%)
o Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 Asia – Market size and forecast 2023-2028
o Exhibit 67: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.4 North America – Market size and forecast 2023-2028
o Exhibit 71: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.5 Europe – Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 83: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 China – Market size and forecast 2023-2028
o Exhibit 87: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 Canada – Market size and forecast 2023-2028
o Exhibit 95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AdvaCare Pharma
o Exhibit 111: AdvaCare Pharma – Overview
o Exhibit 112: AdvaCare Pharma – Product / Service
o Exhibit 113: AdvaCare Pharma – Key offerings
o 12.4 Bausch Lomb Corp.
o Exhibit 114: Bausch Lomb Corp. – Overview
o Exhibit 115: Bausch Lomb Corp. – Business segments
o Exhibit 116: Bausch Lomb Corp. – Key news
o Exhibit 117: Bausch Lomb Corp. – Key offerings
o Exhibit 118: Bausch Lomb Corp. – Segment focus
o 12.5 ENTOD INTERNATIONAL
o Exhibit 119: ENTOD INTERNATIONAL – Overview
o Exhibit 120: ENTOD INTERNATIONAL – Key offerings
o 12.6 Eyenovia Inc.
o Exhibit 121: Eyenovia Inc. – Overview
o Exhibit 122: Eyenovia Inc. – Key offerings
o 12.7 Gmt Pharma
o Exhibit 123: Gmt Pharma – Overview
o Exhibit 124: Gmt Pharma – Product / Service
o Exhibit 125: Gmt Pharma – Key offerings
o 12.8 ISKON REMEDIES and GMT
o Exhibit 126: ISKON REMEDIES and GMT – Overview
o Exhibit 127: ISKON REMEDIES and GMT – Product / Service
o Exhibit 128: ISKON REMEDIES and GMT – Key offerings
o 12.9 Jawa Pharmaceuticals INDIA Pvt. Ltd.
o Exhibit 129: Jawa Pharmaceuticals INDIA Pvt. Ltd. – Overview
o Exhibit 130: Jawa Pharmaceuticals INDIA Pvt. Ltd. – Product / Service
o Exhibit 131: Jawa Pharmaceuticals INDIA Pvt. Ltd. – Key offerings
o 12.10 Medizia Biotech
o Exhibit 132: Medizia Biotech – Overview
o Exhibit 133: Medizia Biotech – Product / Service
o Exhibit 134: Medizia Biotech – Key offerings
o 12.11 OSRX Inc.
o Exhibit 135: OSRX Inc. – Overview
o Exhibit 136: OSRX Inc. – Product / Service
o Exhibit 137: OSRX Inc. – Key offerings
o 12.12 Raymed Pharmaceutical Ltd.
o Exhibit 138: Raymed Pharmaceutical Ltd. – Overview
o Exhibit 139: Raymed Pharmaceutical Ltd. – Product / Service
o Exhibit 140: Raymed Pharmaceutical Ltd. – Key offerings
o 12.13 Santen Pharmaceutical Co. Ltd.
o Exhibit 141: Santen Pharmaceutical Co. Ltd. – Overview
o Exhibit 142: Santen Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 143: Santen Pharmaceutical Co. Ltd. – Key offerings
o 12.14 Sydnexis Inc.
o Exhibit 144: Sydnexis Inc. – Overview
o Exhibit 145: Sydnexis Inc. – Product / Service
o Exhibit 146: Sydnexis Inc. – Key offerings
o 12.15 Tache Pharmacy
o Exhibit 147: Tache Pharmacy – Overview
o Exhibit 148: Tache Pharmacy – Product / Service
o Exhibit 149: Tache Pharmacy – Key offerings
o 12.16 Taiwan Biotech Co.,Ltd
o Exhibit 150: Taiwan Biotech Co.,Ltd – Overview
o Exhibit 151: Taiwan Biotech Co.,Ltd – Product / Service
o Exhibit 152: Taiwan Biotech Co.,Ltd – Key offerings
o 12.17 Vyluma
o Exhibit 153: Vyluma – Overview
o Exhibit 154: Vyluma – Product / Service
o Exhibit 155: Vyluma – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 156: Inclusions checklist
o Exhibit 157: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 158: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 159: Research methodology
o Exhibit 160: Validation techniques employed for market sizing
o Exhibit 161: Information sources
o 13.5 List of abbreviations
o Exhibit 162: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global low-concentration atropine market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Type Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Application Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Type – Market share 2023-2028 (%)
Exhibits31: Data Table on Type – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Atropine sulfate 0.01 percentage – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Atropine sulfate 0.01 percentage – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Atropine sulfate 0.01 percentage – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Atropine sulfate 0.01 percentage – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Atropine sulfate 0.025 percentage – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Atropine sulfate 0.025 percentage – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Atropine sulfate 0.025 percentage – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Atropine sulfate 0.025 percentage – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Atropine sulfate 0.05 percentage – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Atropine sulfate 0.05 percentage – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Atropine sulfate 0.05 percentage – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Atropine sulfate 0.05 percentage – Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Chart on Application – Market share 2023-2028 (%)
Exhibits49: Data Table on Application – Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Child – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Child – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Child – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Child – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Adult – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Adult – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Adult – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Adult – Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2023-2028 (%)
Exhibits64: Data Table on Market share by geography 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AdvaCare Pharma – Overview
Exhibits112: AdvaCare Pharma – Product / Service
Exhibits113: AdvaCare Pharma – Key offerings
Exhibits114: Bausch Lomb Corp. – Overview
Exhibits115: Bausch Lomb Corp. – Business segments
Exhibits116: Bausch Lomb Corp. – Key news
Exhibits117: Bausch Lomb Corp. – Key offerings
Exhibits118: Bausch Lomb Corp. – Segment focus
Exhibits119: ENTOD INTERNATIONAL – Overview
Exhibits120: ENTOD INTERNATIONAL – Key offerings
Exhibits121: Eyenovia Inc. – Overview
Exhibits122: Eyenovia Inc. – Key offerings
Exhibits123: Gmt Pharma – Overview
Exhibits124: Gmt Pharma – Product / Service
Exhibits125: Gmt Pharma – Key offerings
Exhibits126: ISKON REMEDIES and GMT – Overview
Exhibits127: ISKON REMEDIES and GMT – Product / Service
Exhibits128: ISKON REMEDIES and GMT – Key offerings
Exhibits129: Jawa Pharmaceuticals INDIA Pvt. Ltd. – Overview
Exhibits130: Jawa Pharmaceuticals INDIA Pvt. Ltd. – Product / Service
Exhibits131: Jawa Pharmaceuticals INDIA Pvt. Ltd. – Key offerings
Exhibits132: Medizia Biotech – Overview
Exhibits133: Medizia Biotech – Product / Service
Exhibits134: Medizia Biotech – Key offerings
Exhibits135: OSRX Inc. – Overview
Exhibits136: OSRX Inc. – Product / Service
Exhibits137: OSRX Inc. – Key offerings
Exhibits138: Raymed Pharmaceutical Ltd. – Overview
Exhibits139: Raymed Pharmaceutical Ltd. – Product / Service
Exhibits140: Raymed Pharmaceutical Ltd. – Key offerings
Exhibits141: Santen Pharmaceutical Co. Ltd. – Overview
Exhibits142: Santen Pharmaceutical Co. Ltd. – Product / Service
Exhibits143: Santen Pharmaceutical Co. Ltd. – Key offerings
Exhibits144: Sydnexis Inc. – Overview
Exhibits145: Sydnexis Inc. – Product / Service
Exhibits146: Sydnexis Inc. – Key offerings
Exhibits147: Tache Pharmacy – Overview
Exhibits148: Tache Pharmacy – Product / Service
Exhibits149: Tache Pharmacy – Key offerings
Exhibits150: Taiwan Biotech Co.,Ltd – Overview
Exhibits151: Taiwan Biotech Co.,Ltd – Product / Service
Exhibits152: Taiwan Biotech Co.,Ltd – Key offerings
Exhibits153: Vyluma – Overview
Exhibits154: Vyluma – Product / Service
Exhibits155: Vyluma – Key offerings
Exhibits156: Inclusions checklist
Exhibits157: Exclusions checklist
Exhibits158: Currency conversion rates for US$
Exhibits159: Research methodology
Exhibits160: Validation techniques employed for market sizing
Exhibits161: Information sources
Exhibits162: List of abbreviations